Social Support, Treatment Adherence and Outcome Among Hypertensive and Type 2 Diabetes Patients in Ambulatory Care Settings in Southwestern Nigeria

Overview

Journal Ghana Med J

Specialty General Medicine

Date 2017 Sep 29

PMID 28955102

Citations 15

Authors

Rasaq Adisa

Olamide O Olajide

Titilayo O Fakeye

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate available and desired sources and types of social-support among hypertensive and type-2-diabetes (T2D) patients. Associations of medication adherence and clinical outcome with access to most available social-support and medicine affordability were subsequently investigated.

Design: Cross-sectional questionnaire-guided interview among 250-hypertensive and 200-T2D patients, and review of medical records to retrieve disease-specific clinical parameters.

Settings: University College Hospital and Ring-Road State Hospital, Ibadan, southwestern Nigeria.

Participants: Adults out-patients with hypertension, T2D, and T2D comorbid with hypertension were enrolled, while in-patients were excluded.

Results: Family source of support was the most available [hypertensive (225; 90.0%); T2D (174; 87.0%)], but government and non-governmental organisation support were largely desired, with financial support preferred, 233(93.2%) hypertensive and 190(95.0%) T2D, respectively. Adherent hypertensive patients with or without access to family support were (127; 56.4%) versus (18; 72.0%), p=0.135; while for T2D were (103; 59.2%) versus (21; 80.8%), p=0.035. Mean systolic blood pressure of hypertensive and fasting plasma glucose of T2D with access to family and financial support were better than their counterparts without access (p>0.05). Hypertensive (110; 76.4%) and T2D (87; 87.0%) participants who consistently afford medicine expenses had significantly better adherence and outcome (p<0.05).

Conclusions: Family source of support is the most accessible, but government and non-governmental organisation support were largely desired. Access to family support did not positively influence medication adherence, while access to financial support marginally impacted on outcome among hypertensive and T2D patients. However, unwavering tendency for therapy affordability significantly influenced adherence and outcome, thus, the need for expanded social-support system in order to consistently ensure improved outcome.

Funding: None declared.

Citing Articles

Factors affecting treatment adherence among patients with hypertension based on the PRECEDE model: A cross-sectional study from a delay discounting perspective.

Hu Z, Zhang H, Sun Y, Wang Y, Meng R, Shen K Int J Clin Health Psychol. 2025; 25(1):100553.

PMID: 39995511 PMC: 11849083. DOI: 10.1016/j.ijchp.2025.100553.

Social connection as a critical factor for mental and physical health: evidence, trends, challenges, and future implications.

Holt-Lunstad J World Psychiatry. 2024; 23(3):312-332.

PMID: 39279411 PMC: 11403199. DOI: 10.1002/wps.21224.

Role of Perceived Social Support in Adherence to Antihypertensives and Controlled Hypertension: Findings of a Community Survey from Urban Nepal.

Bhattarai S, Wagle D, Shrestha A, Asvold B, Skovlund E, Sen A Patient Prefer Adherence. 2024; 18:767-777.

PMID: 38558834 PMC: 10981373. DOI: 10.2147/PPA.S455511.

Barriers and Facilitators of Medication Adherence in Hypertension Patients: A Meta-Integration of Qualitative Research.

Zhou X, Zhang X, Gu N, Cai W, Feng J J Patient Exp. 2024; 11:23743735241241176.

PMID: 38549805 PMC: 10976505. DOI: 10.1177/23743735241241176.

Unmet and unperceived needs for type 2 diabetes self-management among slum dwellers in Iran: a cross-sectional study.

Ghammari F, Jalilian H, Gholizadeh M Prim Health Care Res Dev. 2024; 25:e14.

PMID: 38482863 PMC: 10940197. DOI: 10.1017/S1463423624000045.

References

Ushie B, Jegede A . The paradox of family support: concerns of tuberculosis-infected HIV patients about involving family and friends in their treatment. AIDS Patient Care STDS. 2012; 26(11):674-80. DOI: 10.1089/apc.2011.0304. View

Eaddy M, Cook C, ODay K, Burch S, Cantrell C . How patient cost-sharing trends affect adherence and outcomes: a literature review. P T. 2012; 37(1):45-55. PMC: 3278192. View

Amos A, McCarty D, Zimmet P . The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997; 14 Suppl 5:S1-85. View

MacLaughlin E, Raehl C, Treadway A, Sterling T, Zoller D, Bond C . Assessing medication adherence in the elderly: which tools to use in clinical practice?. Drugs Aging. 2005; 22(3):231-55. DOI: 10.2165/00002512-200522030-00005. View

Ramli A, Ahmad N, Paraidathathu T . Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence. 2012; 6:613-22. PMC: 3437910. DOI: 10.2147/PPA.S34704. View

. Economic costs of diabetes in the U.S. In 2007. Diabetes Care. 2008; 31(3):596-615. DOI: 10.2337/dc08-9017. View

Holt R, Kalra S . A new DAWN: Improving the psychosocial management of diabetes. Indian J Endocrinol Metab. 2013; 17(Suppl 1):S95-9. PMC: 3830378. DOI: 10.4103/2230-8210.119515. View

Leive A, Xu K . Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Organ. 2008; 86(11):849-856. PMC: 2649544. DOI: 10.2471/blt.07.049403. View

Piette J, Beard A, Rosland A, McHorney C . Beliefs that influence cost-related medication non-adherence among the "haves" and "have nots" with chronic diseases. Patient Prefer Adherence. 2011; 5:389-96. PMC: 3176178. DOI: 10.2147/PPA.S23111. View

10.

Penninx B, van Tilburg T, Kriegsman D, Deeg D, Boeke A, van Eijk J . Effects of social support and personal coping resources on mortality in older age: the Longitudinal Aging Study Amsterdam. Am J Epidemiol. 1997; 146(6):510-9. DOI: 10.1093/oxfordjournals.aje.a009305. View

11.

Wagner E, Glasgow R, Davis C, Bonomi A, Provost L, McCulloch D . Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001; 27(2):63-80. DOI: 10.1016/s1070-3241(01)27007-2. View

12.

Carter-Edwards L, Skelly A, Spence Cagle C, Appel S . "They care but don't understand": family support of African American women with type 2 diabetes. Diabetes Educ. 2004; 30(3):493-501. DOI: 10.1177/014572170403000321. View

13.

Ogah O . Hypertension in Sub-Saharan African populations: the burden of hypertension in Nigeria. Ethn Dis. 2006; 16(4):765. View

14.

. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):854-65. View

15.

Kankeu H, Saksena P, Xu K, Evans D . The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst. 2013; 11:31. PMC: 3751656. DOI: 10.1186/1478-4505-11-31. View

16.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

17.

Briesacher B, Gurwitz J, Soumerai S . Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007; 22(6):864-71. PMC: 2219866. DOI: 10.1007/s11606-007-0180-x. View

18.

Osterberg L, Blaschke T . Adherence to medication. N Engl J Med. 2005; 353(5):487-97. DOI: 10.1056/NEJMra050100. View

19.

Hovstadius B, Petersson G . Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study. BMC Health Serv Res. 2011; 11:326. PMC: 3248911. DOI: 10.1186/1472-6963-11-326. View

20.

Onwujekwe O, Uzochukwu B, Obikeze E, Okoronkwo I, Ochonma O, Onoka C . Investigating determinants of out-of-pocket spending and strategies for coping with payments for healthcare in southeast Nigeria. BMC Health Serv Res. 2010; 10:67. PMC: 2851710. DOI: 10.1186/1472-6963-10-67. View